Coatsome-replicon vehicles: Self-replicating RNA vaccines against infectious diseases.

[1]  Hiroki Tanaka,et al.  Improvement of mRNA Delivery Efficiency to a T Cell Line by Modulating PEG-Lipid Content and Phospholipid Components of Lipid Nanoparticles , 2021, Pharmaceutics.

[2]  Xiang-tao Liu,et al.  Advanced Research in Porcine Reproductive and Respiratory Syndrome Virus Co-infection With Other Pathogens in Swine , 2021, Frontiers in Veterinary Science.

[3]  K. McCullough,et al.  Self-Amplifying Pestivirus Replicon RNA Encoding Influenza Virus Nucleoprotein and Hemagglutinin Promote Humoral and Cellular Immune Responses in Pigs , 2021, Frontiers in Immunology.

[4]  A. Geall,et al.  An Update on Self-Amplifying mRNA Vaccine Development , 2020, Vaccines.

[5]  K. Bloom,et al.  Self-amplifying RNA vaccines for infectious diseases , 2020, Gene Therapy.

[6]  Daiki Matsuda,et al.  A single dose of self-transcribing and replicating RNA-based SARS-CoV-2 vaccine produces protective adaptive immunity in mice , 2020, bioRxiv.

[7]  Ö. Türeci,et al.  A Trans-amplifying RNA Vaccine Strategy for Induction of Potent Protective Immunity. , 2020, Molecular therapy : the journal of the American Society of Gene Therapy.

[8]  Hiroki Tanaka,et al.  Development of an Alcohol Dilution-Lyophilization Method for Preparing Lipid Nanoparticles Containing Encapsulated siRNA. , 2018, Biological & pharmaceutical bulletin.

[9]  H. Yokota,et al.  A hepatic pDNA delivery system based on an intracellular environment sensitive vitamin E‐scaffold lipid‐like material with the aid of an anti‐inflammatory drug , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[10]  K. McCullough,et al.  Self-Amplifying Replicon RNA Delivery to Dendritic Cells by Cationic Lipids , 2018, Molecular therapy. Nucleic acids.

[11]  C. Nathues,et al.  Modelling the economic efficiency of using different strategies to control Porcine Reproductive & Respiratory Syndrome at herd level. , 2018, Preventive veterinary medicine.

[12]  T. Ebensen,et al.  Influenza-Activated ILC1s Contribute to Antiviral Immunity Partially Influenced by Differential GITR Expression , 2018, Front. Immunol..

[13]  U. Şahin,et al.  Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA Vaccines but at Much Lower Doses , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

[14]  K. McCullough,et al.  Self‐replicating RNA vaccine functionality modulated by fine‐tuning of polyplex delivery vehicle structure , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[15]  N. Ruggli,et al.  Virus replicon particle vaccines expressing nucleoprotein of influenza A virus mediate enhanced inflammatory responses in pigs , 2017, Scientific Reports.

[16]  R. Cox,et al.  Mucosal Administration of Cycle-Di-Nucleotide-Adjuvanted Virosomes Efficiently Induces Protection against Influenza H5N1 in Mice , 2017, Front. Immunol..

[17]  Rolf Suter,et al.  Polyethylenimine-based polyplex delivery of self-replicating RNA vaccines. , 2016, Nanomedicine : nanotechnology, biology, and medicine.

[18]  J. Hiscox,et al.  Porcine Reproductive and Respiratory Syndrome Virus Nucleocapsid Protein Interacts with Nsp9 and Cellular DHX9 To Regulate Viral RNA Synthesis , 2016, Journal of Virology.

[19]  S. Suradhat,et al.  Transdermal delivery of plasmid encoding truncated nucleocapsid protein enhanced PRRSV-specific immune responses. , 2016, Vaccine.

[20]  H. Harashima,et al.  Molecular Tuning of a Vitamin E-Scaffold pH-Sensitive and Reductive Cleavable Lipid-like Material for Accelerated in Vivo Hepatic siRNA Delivery. , 2015, ACS biomaterials science & engineering.

[21]  S. Suradhat,et al.  A novel DNA vaccine for reduction of PRRSV-induced negative immunomodulatory effects: A proof of concept. , 2015, Vaccine.

[22]  T. Ebensen,et al.  Inverse micellar sugar glass (IMSG) nanoparticles for transfollicular vaccination. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[23]  H. Harashima,et al.  A neutral lipid envelope-type nanoparticle composed of a pH-activated and vitamin E-scaffold lipid-like material as a platform for a gene carrier targeting renal cell carcinoma. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[24]  K. Ljungberg,et al.  Self-replicating alphavirus RNA vaccines , 2015, Expert review of vaccines.

[25]  S. Konishi,et al.  Neutralized Nanoparticle Composed of SS‐Cleavable and pH‐Activated Lipid‐Like Material as a Long‐Lasting and Liver‐Specific Gene Delivery System , 2014, Advanced healthcare materials.

[26]  Isabelle Bassi,et al.  Self-replicating Replicon-RNA Delivery to Dendritic Cells by Chitosan-nanoparticles for Translation In Vitro and In Vivo , 2014, Molecular therapy. Nucleic acids.

[27]  H. Harashima,et al.  A Neutral Envelope‐Type Nanoparticle Containing pH‐Responsive and SS‐Cleavable Lipid‐Like Material as a Carrier for Plasmid DNA , 2013, Advanced healthcare materials.

[28]  John A. Robinson,et al.  Synthetic Virus-Like Particles Target Dendritic Cell Lipid Rafts for Rapid Endocytosis Primarily but Not Exclusively by Macropinocytosis , 2012, PloS one.

[29]  J. Roth,et al.  Role of porcine reproductive and respiratory syndrome virus nucleocapsid protein in induction of interleukin-10 and regulatory T-lymphocytes (Treg). , 2012, The Journal of general virology.

[30]  W. Charerntantanakul.  Porcine reproductive and respiratory syndrome virus vaccines: Immunogenicity, efficacy and safety aspects. , 2012, World journal of virology.

[31]  K. Ljungberg,et al.  Intradermal Electroporation of Naked Replicon RNA Elicits Strong Immune Responses , 2012, PloS one.

[32]  K. McCullough,et al.  Chicken Cells Sense Influenza A Virus Infection through MDA5 and CARDIF Signaling Involving LGP2 , 2011, Journal of Virology.

[33]  R. Cox,et al.  Evaluation of the Sublingual Route for Administration of Influenza H5N1 Virosomes in Combination with the Bacterial Second Messenger c-di-GMP , 2011, PloS one.

[34]  T. Ebensen,et al.  Bis-(3',5')-cyclic dimeric adenosine monophosphate: strong Th1/Th2/Th17 promoting mucosal adjuvant. , 2011, Vaccine.

[35]  R. Cox,et al.  Intranasal c-di-GMP-adjuvanted plant-derived H5 influenza vaccine induces multifunctional Th1 CD4+ cells and strong mucosal and systemic antibody responses in mice. , 2011, Vaccine.

[36]  Y. Ni,et al.  A modified live PRRSV vaccine and the pathogenic parent strain induce regulatory T cells in pigs naturally infected with Mycoplasma hyopneumoniae. , 2011, Veterinary immunology and immunopathology.

[37]  J. Tratschin,et al.  Immunogenic and replicative properties of classical swine fever virus replicon particles modified to induce IFN-α/β and carry foreign genes. , 2011, Vaccine.

[38]  G. Atkins,et al.  Electroporation of RNA stimulates immunity to an encoded reporter gene in mice. , 2009, Molecular medicine reports.

[39]  J. Tratschin,et al.  Classical Swine Fever Virus Npro Interacts with Interferon Regulatory Factor 3 and Induces Its Proteasomal Degradation , 2007, Journal of Virology.

[40]  J. Tratschin,et al.  Classical swine fever virus replicon particles lacking the Erns gene: a potential marker vaccine for intradermal application. , 2006, Veterinary research.

[41]  C. Mandl,et al.  Mimicking live flavivirus immunization with a noninfectious RNA vaccine , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[42]  J. Rayner,et al.  Alphavirus vectors and vaccination , 2002, Reviews in medical virology.

[43]  J. Tratschin,et al.  Nucleotide sequence of classical swine fever virus strain Alfort/187 and transcription of infectious RNA from stably cloned full-length cDNA , 1996, Journal of virology.

[44]  V. Moennig,et al.  Preliminary serological characterization of bovine viral diarrhoea virus strains using monoclonal antibodies. , 1986, Veterinary microbiology.

[45]  K. McCullough,et al.  Self-Replicating RNA Vaccine Delivery to Dendritic Cells. , 2017, Methods in molecular biology.

[46]  S. Suradhat,et al.  Positive immunomodulatory effects of heterologous DNA vaccine- modified live vaccine, prime-boost immunization, against the highly-pathogenic PRRSV infection. , 2017, Veterinary immunology and immunopathology.

[47]  T. Ebensen,et al.  Efficient nanoparticle-mediated needle-free transcutaneous vaccination via hair follicles requires adjuvantation. , 2015, Nanomedicine : nanotechnology, biology, and medicine.

[48]  V. Moennig,et al.  Identification of conserved epitopes on a hog cholera virus protein , 2005, Archives of Virology.

[49]  J. Shadduck,et al.  Establishment, viral susceptibility and biological characteristics of a swine kidney cell line SK-6. , 1972, Research in veterinary science.